Compare HTT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
High Templar Tech Limited American depositary shares each representing one Class A ordinary share
Current Price
| Metric | HTT | SOPH |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | China | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.3M | 462.3M |
| IPO Year | 2017 | 2021 |
| Metric | HTT | SOPH |
|---|---|---|
| Price | $2.41 | $8.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 73.7K | ★ 625.7K |
| Earning Date | 05-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | $4.14 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.88 | $3.75 |
| 52 Week High | $3.91 | $8.98 |
| Indicator | HTT | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 38.77 | 52.48 |
| Support Level | $2.34 | $4.63 |
| Resistance Level | $2.69 | $8.84 |
| Average True Range (ATR) | 0.07 | 0.38 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 13.79 | 51.62 |
High Templar Tech Ltd is an enabler of financial technology. High Templar is focusing on exploring business opportunities globally to satisfy clients' demand by leveraging its technology know-how and financial service capabilities. The company focus empowering financial institutions with its technological capabilities, helping them improve marketing and operational efficiency and efficiently connect their diverse financial products with online traffic.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.